Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White

NCT00847860 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT00847860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
June 30, 2011
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, vascular dementia